Cancer Biology

Exploiting Embryonic Niche Conditions to Grow Wilms Tumor Blastema in Culture
Heather M. Wojcik, Harold N. Lovvorn III, Melinda Hollingshead, Janene Pierce, Howard Stotler, Andrew J. Murphy, Suzanne Borgel, Hannah M. Phelps, Hernan Correa, Alan O. Perantoni

bioRxiv 2022.11.07.515473; doi: https://doi.org/10.1101/2022.11.07.515473

Add to Selected Citations
Targeting BRPF3 moderately reverses olaparib resistance in high grade serous ovarian carcinoma
Benjamin G. Bitler, Tomomi M. Yamamoto, Alexandra McMellen, Hyunmin Kim, Zachary L. Watson

bioRxiv 2021.12.21.473688; doi: https://doi.org/10.1101/2021.12.21.473688

Add to Selected Citations
Mitochondrial Function is Preserved Under Cysteine Starvation via Glutathione Catabolism in NSCLC
Nathan P. Ward, Sang Jun Yoon, Tyce Flynn, Amanda Sherwood, Juliana Madej, Gina M. DeNicola

bioRxiv 2022.10.06.511221; doi: https://doi.org/10.1101/2022.10.06.511221

Add to Selected Citations
Downregulation of dystrophin expression occurs across diverse tumors, correlates with the age of onset, staging and reduced survival of patients
Nancy Alnassar, Malgorzata Borczyk, Georgia Tsagkogeorga, Michal Korostynski, Namshik Han, Dariusz C Górecki

bioRxiv 2022.04.04.486990; doi: https://doi.org/10.1101/2022.04.04.486990

Add to Selected Citations
The Siglec-sialic acid-axis is a target for innate immunotherapy of glioblastoma
Philip Schmassmann, Julien Roux, Alicia Buck, Nazanin Tatari, Sabrina Hogan, Jinyu Wang, Sohyon Lee, Berend Snijder, Tomás A. Martins, Marie-Françoise Ritz, Tala Shekarian, Deniz Kaymak, Marta McDaid, Michael Weller, Tobias Weiss, Heinz Läubli, Gregor Hutter

bioRxiv 2022.11.07.515406; doi: https://doi.org/10.1101/2022.11.07.515406

Add to Selected Citations
Understanding and leveraging phenotypic plasticity during metastasis formation
Saumil Shah, Lisa-Marie Philipp, Susanne Sebens, Arne Traulsen, Michael Raatz

bioRxiv 2022.11.07.515430; doi: https://doi.org/10.1101/2022.11.07.515430

Add to Selected Citations
Immunogenicity of non-canonical HLA-I tumor ligands identified through proteogenomics
Maria Lozano-Rabella, Andrea Garcia-Garijo, Jara Palomero, Anna Yuste-Estevanez, Florian Erhard, Juan Martín-Liberal, Maria Ochoa de Olza, Ignacio Matos, Jared J. Gartner, Michael Ghosh, Francesc Canals, August Vidal, Josep Maria Piulats, Xavier Matias-Guiu, Irene Braña, Eva Muñoz-Couselo, Elena Garralda, Andreas Schlosser, Alena Gros

bioRxiv 2022.11.07.514886; doi: https://doi.org/10.1101/2022.11.07.514886

Add to Selected Citations
PKM2-mediated epigenetic reprogramming regulates hypoxic expression of PFKFB3 to promote breast cancer progression
Madhura R. Pandkar, Adarsh Raveendran, Kajal Biswas, Srinivas Abhishek Mutnuru, Jharna Mishra, Atul Samaiya, Shyam K. Sharan, Sanjeev Shukla

bioRxiv 2022.11.06.515384; doi: https://doi.org/10.1101/2022.11.06.515384

Add to Selected Citations
Tumor-educated Gr1⁺CD11b⁺ cells instigate breast cancer metastasis by twisting cancer cells plasticity via OSM/IL6–JAK signaling
Sanam Peyvandi, Manon Bulliard, Annamaria Kauzlaric, Oriana Coquoz, Yu-Ting Huang, Nathalie Duffey, Laetitia Gafner, Girieca Lorusso, Nadine Fournier, Qiang Lan, Curzio Rüegg

bioRxiv 2022.10.26.513889; doi: https://doi.org/10.1101/2022.10.26.513889

Add to Selected Citations
Repurposing clemastine to target glioblastoma cell stemness
Michael A. Sun, Rui Yang, Heng Liu, Wenzhe Wang, Xiao Song, Bo Hu, Nathan Reynolds, Kristen Roso, Lee H. Chen, Paula K. Greer, Stephen T. Keir, Roger E. McLendon, Shi-Yuan Cheng, Darell D. Bigner, David M. Ashley, Christopher J. Pirozzi, Yiping He

bioRxiv 2022.11.05.515291; doi: https://doi.org/10.1101/2022.11.05.515291

Add to Selected Citations

Cancer Biology

Pages